Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Elsevier Announces Its Official Collaboration With ROSATOM, Russia's Leading Atomic Energy Corporation



 Elsevier Announces Its Official Collaboration With ROSATOM, Russia's Leading
                          Atomic Energy Corporation

  PR Newswire

  MOSCOW, February 5, 2013

MOSCOW, February 5, 2013 /PRNewswire/ --

   Collaboration provides ROSATOM with access to ScienceDirect and Scopus,
   fostering international expertise and the launch of new technologies and
                      innovations in safe nuclear energy

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, announced today its collaboration with
Russia's State Atomic Energy Corporation (ROSATOM), providing ROSATOM's major
affiliated research organizations with access to Elsevier's ScienceDirect and
Scopus .

ROSATOM unites a number of Russia's key enterprises focusing on atomic power
engineering, nuclear and radiation safety and fundamental and applied research
in the creation of structural materials and technologies. The corporation
actively participates in international energy research and develops innovative
technologies in water treatment, new isotopes for medicine and in
superconductivity. By providing more than ten of its key enterprises with
access to ScienceDirect and Scopus, ROSATOM will help these institutes to
significantly advance and accelerate their research and innovation in atomic
energy.

Svetlana Sheveleva, Deputy Director on Innovation Complex at ROSATOM, said,
"As one of the world's leaders in atomic energy, we aim to be a world-class
research organization. Our research leads to the discovery of new technologies
in medicine, material science and other actual fundamental and applied areas.
Without access to world-class scientific information, resources and tools,
this would not be possible. Our collaboration with Elsevier helps us reach our
objectives."

Igor Osipov, PhD, Regional Director at Elsevier Russia and Belarus, added,
"Rosatom is one of the global leaders in safe nuclear energy research and we
have collaborated with their flagship R&D think tank - Russian Federal Nuclear
Center (RFNC-VNIIEF) for many years. We are happy to take this collaboration
to the next level by providing access to ScienceDirect and Scopus to the
entire network of R&D organization within ROSATOM. Through our agreement with
ROSATOM, Elsevier can contribute to the development of high quality research
and innovation in the Russian and international energy sector."

About ROSATOM

The State Atomic Energy Corporation ROSATOM incorporates more than 250
enterprises and scientific institutions, including all civil nuclear companies
of Russia, nuclear weapons complex's facilities, research organizations and
the world's only nuclear-propelled fleet. ROSATOM is the largest utility in
Russia which produces more than 40 % of electricity in the country's European
part. ROSATOM holds leading positions in the world market of nuclear
technologies being the 1-st in the world simultaneous nuclear build abroad;
2-nd in uranium reserves and 5-th in uranium mining; 4-th in nuclear
electricity generation, while providing 40% of the world uranium enrichment
services and 17% of the world nuclear fuel market. ROSATOM is also tasked to
fulfill Russia's international obligations in the field of the peaceful uses
of atomic energy and nuclear nonproliferation regime.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
provider of professional information solutions in the Science, Medical, Legal
and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and
Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Galina Yakshonak Elsevier, Russia +7-985-72-779-67 g.yakshonak@elsevier.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement